Candriam Equities L Biotechnology Class R2 Fonds
290,69
USD
+2,52
USD
+0,87
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,86% |
| Amgen Inc | US0311621009 | 4,92% |
| Gilead Sciences Inc | US3755581036 | 4,85% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,38% |
| Insmed Inc | US4576693075 | 4,02% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,02% |
| BeOne Medicines Ltd ADR | US07725L1026 | 3,20% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,91% |
| argenx SE | NL0010832176 | 2,40% |
| BioNTech SE ADR | US09075V1026 | 2,39% |
| Sonstige | 60,06% |